经皮椎体后凸成形术联合125I放射粒子植入治疗脊柱转移瘤的疗效探析

  • 格式:pdf
  • 大小:1.32 MB
  • 文档页数:42

Ningxia Medical University Thesis for Application of Master’s DegreeT o evaluate effectiveness by percutaneous kyphoplasty(PKP) combined with 125I in patients with the metastatic spinaltumorsStudent’s Name: supervisor: Subject Category: Major: Specialty: College: Completion Date: Zhang W eiShi JiandangMedical scienceSurgerySpine NeoplasmsInstitute of Clinical Medicine Apr. 2014宁夏医科大学学位论文独创性声明本人郑重声明:所呈交的学位论文,是个人在导师的指导下,独立进行研究工作所取得的成果,无抄袭及编造行为。

除文中已经特别加以注明引用的内容外,本论文不含任何其他个人或集体已经发表或撰写过的作品成果。

对本文的研究做出重要贡献的个人和集体,均已在文中以明确方式标明并致谢。

本人完全意识到本声明的法律结果由本人承担。

论文作者签名_____论文导师签名_____年月日年月日宁夏医科大学学位论文使用授权的声明宁夏医科大学有权保留使用本人学位论文,同意学校按规定向国家有关部门机构送交论文的复印件和电子版,允许被查阅和借阅。

本人授权宁夏医科大学可以将本学位论文的全部或部分内容编入有关数据库进行检索,可以采用影印、缩印或其他复印手段保存和汇编本学位论文。

可以公布(包括刊登)论文的全部或部分内容。

(保密论文在解密后应遵守此规定)论文作者签名_____论文导师签名_____年月日年月日经皮椎体后凸成形术联合125I放射粒子植入治疗脊柱转移瘤的疗效分析摘要目的观察经皮球囊扩张椎体后凸成形术联合125I放射粒子治疗脊柱转移瘤的疗效。

方法回顾性分析2011年3月至2012年7月我科接受椎体成形术治疗的60例脊柱转移瘤患者,其中经皮椎体后凸成形术联合125I放射粒子植入治疗组30例,单独应用经皮球囊扩张椎体后凸成形术治疗组30例。

收集患者的症状、体征、影像学表现,患者治疗前均有顽固性背痛,CT提示有椎体骨质破坏。

各组分别采用目测类比评分、WHO疼痛缓解标准、功能障碍指数来评估治疗后临床症状转归及神经功能恢复情况,测量病椎高度变化。

随访时间为治疗后1天、1个月及6个月。

对比经皮椎体后凸成形术联合125I放射粒子植入治疗组与单独采用经皮椎体后凸成形术的指标。

结果两组患者治疗过程顺利,治疗后24 h疼痛缓解,无神经损伤及压迫症状。

治疗后目测类比评分、疼痛缓解情况、功能障碍指数、椎体高度均较治疗前显著改善(P < 0.05)。

联合治疗组治疗后随访1个月及6个月,目测类比评分、功能障碍指数、椎体高度变化与治疗后24 h差异无显著性意义(P > 0.05)。

单独应用PKP治疗组治疗后随访6个月,目测类比评分、功能障碍指数、与治疗后24 h差异有显著性意义(P < 0.05) ,椎体高度变化与治疗后24 h 差异无显著性意义(P >0.05)。

两组间VAS评分、功能障碍指数比较有统计学意义(P < 0.05)。

联合治疗组术后随访未见明显异常;单独采用PKP治疗组,术后6月有4例再次出现椎体骨折及疼痛症状,7例再次出现疼痛症状加重。

结论两种治疗方式均可以短时间内缓解疼痛,但PKP联合放射性125I 放射粒子治疗方式在缓解疼痛具有优势,此方法为晚期及手术耐受性较差的患者提供了新的选择,临床应用方面有一定意义。

关键词:经皮椎体后凸成形术;脊柱转移瘤;疗效;经皮椎体成形术;125ITo evaluate effectiveness by percutaneous kyphoplasty(PKP) combined with 125I in patients with the metastatic spinaltumorsABSTRACTObjective To evaluate safety and effectiveness by percutaneous kyphoplasty (PKP) combined with 125I in patients with the metastatic spinal tumors.Method Were retrospectively analyzed in March 2011 to July 2012, I division underwent vertebral plasty of 60 patients with spinal metastases, one of the protruding after percutaneous vertebral plasty combined 125I radioactive particles into the treatment group 30 cases, single application of percutaneous balloon expansion of the protruding after vertebral plasty treatment group 30 cases. Collect the patient's symptoms, signs, imaging findings, both before treatment in patients with intractable back pain, CT suggesting the vertebral body bone destruction. Groups, respectively, using visual analog score, WHO pain relief, dysfunction index to assess the clinical outcome after treatment and neural function recovery, vertebral height measurement disease changes. Follow-up time is 1 day, 1 month after treatment and 6 months. Comparison of the protruding after percutaneous vertebral plasty combined 125I radioactive particles into the treatment group and individual use index of the protruding after percutaneous vertebral plasty.Results Two groups of patients treatment process smoothly, 24 h after the pain relief, no nerve damage and compression symptoms. Visual analog score after treatment, pain relief, dysfunction index, vertebral body height than before treatment significantly improved (P < 0.05). Combination group were followed up for 1 month and 6 months after treatment, visual analog scores, dysfunction index, vertebral body height change and there was no significant difference in 24 h aftertreatment (P > 0.05). PKP holds the separate application in treatment group after treatment were followed up for 6 months, visual analog scores, functional disturbance index, and significant differences between 24 h after trea tment (P < 0.05), vertebral body height change and there was no significant difference in 24 h after treatment significance (P > 0.05). VAS score, dysfunction index comparison between the two groups was statistically significant (P < 0.05). Postoperative follow-up did not see combined treatment group was obviously abnormal; Separate use PKP holds the treatment group, postoperative June 4 cases of vertebral fractures and pain symptoms again, 7 cases of pain symptoms worsen again.Conclusions Two kinds of treatment may be a short period of time to change patients' pain symptoms, but compared with separate the PKP holds the treatment of vertebral metastases after percutaneous balloon expansion vertebral convex forming joint 125I radioactive particles group treatment of spinal metastases, alleviate the pain caused by a tumor, effectively restore the disease more significant effect of vertebral height, can obviously improve the patients quality of life.KEYWORDS :Percutaneous kyphoplasty; metastatic spinal tumors; Curative effect; Percutaneous V ertebroplasty;125I中英文缩略词表(Abbreviation)英文缩写英文全称中文名称PKP Percutaneous kyphoplasty 球囊扩张椎体后凸成形术PVP Percutaneous vertebroplasty 经皮椎体成形术ODI Owestry disability index 功能障碍指数WHO World health organization 世界卫生组织目录前言1资料与方法.4资料 (4)方法 (5)手术方法 5 主要观察指标及临床疗效评价标准 6 统计学分析 6 结果7讨论.91脊柱转移癌的治疗困境92.PKP及PVP在脊柱转移癌中的应用93.125I粒子在外科领域中的应用.94.PKP与.125I联合应用的疗效及探索105.两者联合应用的注意事项 .11结论12 参考文献13病例资料16附表17综述19综述参考文献31致谢36攻读硕士期间发表的论文 (37)个人简介 (38)宁夏医科大学硕士研究学位论文前言前言脊柱肿瘤大约占全身骨肿瘤的6%~10%,各种类型的骨肿瘤几乎都可以在脊柱见到,如骨肉瘤、骨样骨瘤、动脉瘤样骨囊肿,而转移性骨肿瘤则占脊柱肿瘤半数以上。